MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study

NeuroImage

Volumn 47, Issue 2, 2009, Pages 435-441

  Menke, Ricarda A ^a   Scholz, Jan ^a   Miller, Karla L ^a   Deoni, Sean ^b   Jbabdi, Saad ^a   Matthews, Paul M ^a,c   Zarei, Mojtaba ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION TENSOR IMAGING; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; THALAMUS;

AGED; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA; SUBTRACTION TECHNIQUE;

EID: 67349215018     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.05.017     Document Type: Article

References (42)

1. Adachi M., Hosoya T., Haku T., Yamaguchi K., and Kawanami T. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am. J. Neuroradiol. 20 (1999) 1500-1506
2. Behrens T.E.J., Johansen-Berg H., Woolrich M.W., Smith S.M., Wheeler-Kingshott C.A.M., Boulby P.A., Barker G.J., Sillery E.L., Sheehan K., Ciccarelli O., Thompson A.J., Brady J.M., and Matthews P.M. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat. Neurosci. 6 (2003) 750-757
3. Boska M.D., Hasan K.M., Kibuule D., Banerjee R., McIntyre E., Nelson J.A., Hahn T., Gendelman H.E., and Mosley R.L. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol. Dis. 26 (2007) 590-596
4. Brooks D.J. Detection of preclinical Parkinson's disease with PET. Geriatrics 46 Suppl 1 (1991) 25-30
5. Caslake R., Moore J.N., Gordon J.C., Harris C.E., and Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry 79 (2008) 1202-1207
6. Chan L.-L., Rumpel H., Yap K., Lee E., Loo H.-V., Ho G.-L., Fook-Chong S., Yuen Y., and Tan E.-K. Case control study of diffusion tensor imaging in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007) 1383-1386
7. Christensen K., Grant D., Schulman E., and Walling C. Optimal determination of relaxation-times of Fourier-transform nuclear magnetic-resonance. Determination of spin-lattice relaxation-times in chemically polarized species. J. Phys. Chem. 78 (1974) 1971-1977
8. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 Pt 8 (1999) 1437-1448
9. Deoni S.C.L. High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI). J. Magn. Reson. Imaging 26 (2007) 1106-1111
10. Deoni S.C.L., Rutt B.K., and Peters T.M. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn. Reson. Med. 49 (2003) 515-526
11. Deoni S.C.L., Josseau M.J.C., Rutt B.K., and Peters T.M. Visualization of thalamic nuclei on high resolution, multi-averaged T1 and T2 maps acquired at 1.5 T. Hum. Brain Mapp. 25 (2005) 353-359
12. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., and Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52 (1989) 1830-1836
13. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 Pt 5 (1991) 2283-2301
14. Foster, E., Black, K., Antenor-Dorsey, J., Perlmutter, J., Hershey, T., 2007. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease., Brain Cogn, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Department of Occupational Therapy, Washington University School of Medicine, St. Louis, MO, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
15. Galvan A., and Wichmann T. Pathophysiology of parkinsonism. Clin. Neurophysiol. 119 (2008) 1459-1474
16. Gelman N., Ewing J.R., Gorell J.M., Spickler E.M., and Solomon E.G. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn. Reson. Med. 45 (2001) 71-79
17. Gorell J.M., Ordidge R.J., Brown G.G., Deniau J.C., Buderer N.M., and Helpern J.A. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 45 (1995) 1138-1143
18. Graham J.M., Paley M.N., Grunewald R.A., Hoggard N., and Griffiths P.D. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123 Pt 12 (2000) 2423-2431
19. Homer J., and Beevers M. Driven-equilibrium single-pulse observation of T1 relaxation. A reevaluation of a rapid new method for determining NMR spin-lattice relaxation-times. J. Magn. Reson. 63 (1985) 287-297
20. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
21. Hutchinson M., and Raff U. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J. Neurol. Neurosurg. Psychiatry 67 (1999) 815-818
22. Hutchinson, M., Raff, U., 2008. Detection of Parkinson's disease by MRI: spin-lattice distribution imaging., Mov Disord, Department of Neurology, New York University School of Medicine, New York, USA.
23. Hutchinson M., Raff U., and Lebedev S. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). NeuroImage 20 (2003) 1899-1902
24. Jack C.R.J., Twomey C.K., Zinsmeister A.R., Sharbrough F.W., Petersen R.C., and Cascino G.D. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 172 (1989) 549-554
25. Jenkinson M., and Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5 (2001) 143-156
26. Kitano H., Tanibuchi I., and Jinnai K. The distribution of neurons in the substantia nigra pars reticulata with input from the motor, premotor and prefrontal areas of the cerebral cortex in monkeys. Brain Res. 784 (1998) 228-238
27. Martin, W., Wieler, M., Gee, M., 2008. Midbrain iron content in early Parkinson disease. A potential biomarker of disease status., Neurology, From the Division of Neurology (W.R.W.M., M.W.), and Department of Biomedical Engineering (M.G.), University of Alberta, Edmonton, Canada.
28. Minati L., Grisoli M., Carella F., De Simone T., Bruzzone M.G., and Savoiardo M. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am. J. Neuroradiol. 28 (2007) 309-313
29. Oikawa H., Sasaki M., Tamakawa Y., Ehara S., and Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am. J. Neuroradiol. 23 (2002) 1747-1756
30. Ordidge R.J., Gorell J.M., Deniau J.C., Knight R.A., and Helpern J.A. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn. Reson. Med. 32 (1994) 335-341
31. Patenaude, B., 2007. Bayesian statistical models of shape and appearance for subcortical brain segmentation. D. Phil. Thesis. University of Oxford.
32. Pujol J., Junque C., Vendrell P., Grau J.M., and Capdevila A. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch. Neurol. 49 (1992) 1119-1122
33. Sasaki M., Shibata E., Tohyama K., Takahashi J., Otsuka K., Tsuchiya K., Takahashi S., Ehara S., Terayama Y., and Sakai A. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. NeuroReport 17 (2006) 1215-1218
34. Sasaki, M., Shibata, E., Tohyama, K., Kudo, K., Endoh, J., Otsuka, K., Sakai, A., 2008. Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications., Neuroreport, aAdvanced Medical Research Center bDepartment of Neuropsychiatry cCenter for EM and Bio-Imaging Research, Iwate Medical University, Uchimaru, Morioka, Japan.
35. Sato H. Prefrontal lobe-substantia nigra projection in human cerebrum. Jpn. J. Psychiatry Neurol. 40 (1986) 195-207
36. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002) 143-155
37. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., and Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl 1 (2004) S208-219
38. Stern M.B., Braffman B.H., Skolnick B.E., Hurtig H.I., and Grossman R.I. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39 (1989) 1524-1526
39. Vaillancourt, D., Spraker, M., Prodoehl, J., Abraham, I., Corcos, D., Zhou, X., Comella, C., Little, D., 2009. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease., Neurology, From the Departments of Kinesiology and Nutrition (D.E.V., J.P., I.A., D.M.C.), Bioengineering (D.E.V., M.B.S., D.M.C., X.J.Z.), Neurology and Rehabilitation (D.E.V., D.M.L.), Physical Therapy (D.M.C.), Anatomy and Cell Biology (D.M.L.), Ophthalmology and Visual Sciences (D.M.L.), Psychology (D.M.L.), Neurosurgery (X.J.Z.), and Radiology (X.J.Z.), and Center for MR Research (X.J.Z.), University of Illinois at Chicago; and Department of Neurological Sciences (C.L.C.), Rush University Medical Center, Chicago, IL.
40. Vymazal J., Righini A., Brooks R.A., Canesi M., Mariani C., Leonardi M., and Pezzoli G. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211 (1999) 489-495
41. Walter U., Dressler D., Probst T., Wolters A., Abu-Mugheisib M., Wittstock M., and Benecke R. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch. Neurol. 64 (2007) 1635-1640
42. Yoshikawa K., Nakata Y., Yamada K., and Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J. Neurol. Neurosurg. Psychiatry 75 (2004) 481-484